These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 36230845)

  • 1. Development of a Neurotensin-Derived
    Schindler L; Moosbauer J; Schmidt D; Spruss T; Grätz L; Lüdeke S; Hofheinz F; Meister S; Echtenacher B; Bernhardt G; Pietzsch J; Hellwig D; Keller M
    Cancers (Basel); 2022 Oct; 14(19):. PubMed ID: 36230845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modifications at Arg and Ile Give Neurotensin(8-13) Derivatives with High Stability and Retained NTS
    Schindler L; Bernhardt G; Keller M
    ACS Med Chem Lett; 2019 Jun; 10(6):960-965. PubMed ID: 31223455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (18)F- and (68)Ga-Labeled Neurotensin Peptides for PET Imaging of Neurotensin Receptor 1.
    Maschauer S; Einsiedel J; Hübner H; Gmeiner P; Prante O
    J Med Chem; 2016 Jul; 59(13):6480-92. PubMed ID: 27336295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurotensin analogs by fluoroglycosylation at N
    Schindler L; Wohlfahrt K; Gluhacevic von Krüchten L; Prante O; Keller M; Maschauer S
    Sci Rep; 2022 Sep; 12(1):15028. PubMed ID: 36056076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel DOTA-neurotensin analogues for 111In scintigraphy and 68Ga PET imaging of neurotensin receptor-positive tumors.
    Alshoukr F; Prignon A; Brans L; Jallane A; Mendes S; Talbot JN; Tourwé D; Barbet J; Gruaz-Guyon A
    Bioconjug Chem; 2011 Jul; 22(7):1374-85. PubMed ID: 21662976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of a (68)ga-labeled peptoid-Peptide hybrid for imaging of neurotensin receptor expression in vivo.
    Maschauer S; Einsiedel J; Hocke C; Hübner H; Kuwert T; Gmeiner P; Prante O
    ACS Med Chem Lett; 2010 Aug; 1(5):224-8. PubMed ID: 24900199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Side-Chain Modified [
    Kanellopoulos P; Nock BA; Rouchota M; Loudos G; Krenning EP; Maina T
    Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the Neuropeptide Y1 Receptor for Cancer Imaging by Positron Emission Tomography Using Novel Truncated Peptides.
    Zhang C; Pan J; Lin KS; Dude I; Lau J; Zeisler J; Merkens H; Jenni S; Guérin B; Bénard F
    Mol Pharm; 2016 Nov; 13(11):3657-3664. PubMed ID: 27669056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silicon-Containing Neurotensin Analogues as Radiopharmaceuticals for NTS
    Fanelli R; Chastel A; Previti S; Hindié E; Vimont D; Zanotti-Fregonara P; Fernandez P; Garrigue P; Lamare F; Schollhammer R; Balasse L; Guillet B; Rémond E; Morgat C; Cavelier F
    Bioconjug Chem; 2020 Oct; 31(10):2339-2349. PubMed ID: 32887526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved radiosynthesis and preliminary in vivo evaluation of a (18)F-labeled glycopeptide-peptoid hybrid for PET imaging of neurotensin receptor 2.
    Maschauer S; Greff C; Einsiedel J; Ott J; Tripal P; Hübner H; Gmeiner P; Prante O
    Bioorg Med Chem; 2015 Jul; 23(14):4026-33. PubMed ID: 25691211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative studies of three 68Ga-labeled [Des-Arg10]kallidin derivatives for imaging bradykinin B1 receptor expression with PET.
    Lin KS; Amouroux G; Pan J; Zhang Z; Jenni S; Lau J; Liu Z; Hundal-Jabal N; Colpo N; Bénard F
    J Nucl Med; 2015 Apr; 56(4):622-7. PubMed ID: 25745086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biodistribution and catabolism of (18)F-labeled neurotensin(8-13) analogs.
    Bergmann R; Scheunemann M; Heichert C; Mäding P; Wittrisch H; Kretzschmar M; Rodig H; Tourwé D; Iterbeke K; Chavatte K; Zips D; Reubi JC; Johannsen B
    Nucl Med Biol; 2002 Jan; 29(1):61-72. PubMed ID: 11786277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical PET Imaging of NTSR-1-Positive Tumors with
    Li D; Minnix M; Allen R; Bading J; Chea J; Wong P; Bowles N; Poku E; Shively JE
    Cancer Biother Radiopharm; 2021 Oct; 36(8):651-661. PubMed ID: 32822229
    [No Abstract]   [Full Text] [Related]  

  • 14. Novel neurotensin analogues for radioisotope targeting to neurotensin receptor-positive tumors.
    Alshoukr F; Rosant C; Maes V; Abdelhak J; Raguin O; Burg S; Sarda L; Barbet J; Tourwé D; Pelaprat D; Gruaz-Guyon A
    Bioconjug Chem; 2009 Aug; 20(8):1602-10. PubMed ID: 19610615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical Evaluation of
    Prignon A; Provost C; Alshoukr F; Wendum D; Couvelard A; Barbet J; Forgez P; Talbot JN; Gruaz-Guyon A
    Mol Pharm; 2019 Jun; 16(6):2776-2784. PubMed ID: 31013092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new class of PentixaFor- and PentixaTher-based theranostic agents with enhanced CXCR4-targeting efficiency.
    Osl T; Schmidt A; Schwaiger M; Schottelius M; Wester HJ
    Theranostics; 2020; 10(18):8264-8280. PubMed ID: 32724470
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.